NASDAQ: MEDP
Medpace Holdings, Inc.
Healthcare · Medical - Diagnostics & Research
After hours: $589.15(-0.04%) · as of 6:40 PM ET
Market Cap
$16.45B
52w High
$677.90
52w Low
$373.00
P/E
34.49
Volume
415.43K
Outstanding Shares
27.91M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 30.09% over the last year. Revenue grew 24.67% over the trailing twelve months. Operating margin moved from 21.4% to 20.97%. Free cash flow grew 26.51% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (80th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 20.97% — continued expansion would be needed to justify the premium. Revenue growth of 24.67% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
4
Buy
14
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 28, 2026
Q4 FY26 · EPS est $4.39 · Revenue est $714.27M
View